DaxibotulinumtoxinA for Injection has a prolonged duration of response in the treatment of glabellar lines: Pooled data from two multicenter, randomized, double-blind, placebo-controlled, phase 3 studies (SAKURA 1 and SAKURA 2).

Bertucci, Vince; Solish, Nowell; Kaufman-Janette, Joely; Yoelin, Steve; Shamban, Ava; Schlessinger, Joel; Snyder, Daniel; Gallagher, Conor; Liu, Yan; Shears, Gill; Rubio, Roman G

DaxibotulinumtoxinA for Injection has a prolonged duration of response in the treatment of glabellar lines: Pooled data from two multicenter, randomized, double-blind, placebo-controlled, phase 3 studies (SAKURA 1 and SAKURA 2).

Bertucci, Vince; Solish, Nowell; Kaufman-Janette, Joely; Yoelin, Steve; Shamban, Ava; Schlessinger, Joel; Snyder, Daniel; Gallagher, Conor; Liu, Yan; Shears, Gill; Rubio, Roman G.

Afiliação

Bertucci V; Division of Dermatology, University of Toronto, Toronto, Ontario, Canada; private practice, Woodbridge, Ontario, Canada. Electronic address: vince.bertucci@utoronto.ca.
Solish N; Division of Dermatology, University of Toronto, Toronto, Ontario, Canada.
Kaufman-Janette J; Skin Associates of South Florida, Coral Gables, and Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Coral Gables, California.
Yoelin S; private practice, Newport Beach, California.
Shamban A; private practice, Santa Monica, California.
Schlessinger J; Skin Specialists PC, Omaha, California.
Snyder D; Revance Therapeutics, Inc, Newark, California.
Gallagher C; Revance Therapeutics, Inc, Newark, California.
Liu Y; Revance Therapeutics, Inc, Newark, California.
Shears G; Write on Target Ltd, Leighton Buzzard, United Kingdom.
Rubio RG; Revance Therapeutics, Inc, Newark, California.

J Am Acad Dermatol ; 82(4): 838-845, 2020 Apr.

Article em En | MEDLINE | ID: mdl-31791824

Assuntos

Toxinas Botulínicas Tipo A/uso terapêutico; Técnicas Cosméticas; Fármacos Neuromusculares/uso terapêutico; Envelhecimento da Pele/efeitos dos fármacos; Toxinas Botulínicas Tipo A/efeitos adversos; Músculos Faciais/efeitos dos fármacos; Feminino; Testa; Humanos; Injeções Intramusculares; Masculino; Fármacos Neuromusculares/efeitos adversos; Satisfação do Paciente; Fatores de Tempo

Palavras-chave

DAXI; RT002; RTP004; aesthetic; botulinum toxin; daxibotulinumtoxinA; double-blind; duration; facial rejuvenation; glabellar lines; humans; injection; multicenter; neuromodulator; neuromuscular agent; peptide; phase 3; placebo; pooled; randomized

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Envelhecimento da Pele / Técnicas Cosméticas / Toxinas Botulínicas Tipo A / Fármacos Neuromusculares Tipo de estudo: Clinical_trials Limite: Female / Humans / Male Idioma: En Revista: J Am Acad Dermatol Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google